“Animal growth promoters and performance enhancers are the product offerings which help the animal live-stocks grow into strong and healthy adults, by helping them digest their food more effectively and efficiently by the use of natural, organic and chemicals specifically designed for the purpose.
These products protect the animals from various bacterial and microbial diseases and thereby also provide immunity and resistance from diseases and disorders. Animal growth enhancers help the animals gain more fat and weight which helps in the more amount of flesh production and thereby helps in the more high prices selling of the animals. The decrease in cost of production, along with more and growing demand for more amounts of meat and fat will fuel the growth of this market.
The Animal growth promoters and performance enhancers market has been sub-segmented in detail by type of products and according to the animal industry to give a detailed and comprehensive and procuring in-depth demarcation of the market.
The Animal growth promoters and performance enhancers market has been thoroughly scrutinized and then carefully delineated by geographic locations which are based on major economic regions and their topographical regions. Growing competition and the changing market dynamics has been highlighted. Aggressive market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments. The Market share and Market size prominent players for 2015 are profiled in this report.
The report contains the most detailed and in-depth segmentation and analysis of the Animal growth promoters and performance enhancers Market during the forecast period 2015 – 2020.”
“1. Animal Growth Promoters and Performance Enhancers- Market Overview
2. Executive Summary
3. Animal Growth Promoters and Performance Enhancers – Market Landscape
4. Market Share Analysis
4.1. Comparative Analysis
4.1.1. Product Benchmarking
4.1.2. End user profiling
4.1.3. Patent Analysis
4.1.4. Top 5 Financials Analysis
5. Animal Growth Promoters and Performance Enhancers – Market Forces
5.1. Market Drivers
5.2. Market Constraints
5.3. Market Challenges
5.4. Attractiveness of the Industry
5.4.1. Power of Suppliers
5.4.2. Power of Customers
5.4.3. Threat of New entrants
5.4.4. Threat of Substitution
5.4.5. Degree of Competition
6. Animal Growth Promoters and Performance Enhancers Market – Strategic Analysis
6.1. Value Chain Analysis
6.2. Opportunities Analysis
6.3. Product/Market Life Cycle Analysis
7. Animal Growth Promoters and Performance Enhancers Market – By Type of products
7.1. Herbs, oils and spices
7.2. Hormonal Growth Promoters
7.3. â-agonists
7.4. Prebiotics and Probiotics
7.5. Yeast Products
7.6. Feed Enzymes
7.7. Prebiotics and Probiotics
7.8. Yeast Products
7.9. Herbs, oils and spices
7.10. Microbial products
7.11. Antibiotics
7.12. Organic Acids
7.13. Phytogenics
7.14. Others
8. Animal Growth Promoters and Performance Enhancers Market -By Animal Industry
8.1. Porcine
8.2. Poultry
8.3. Live Stock
8.4. Equine
8.5. Aquaculture
8.6. Other Animals
9. Animal Growth Promoters and Performance Enhancers Market – Geographic Analysis
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Mexico
9.2. Europe
9.2.1. U.K.
9.2.2. France
9.2.3. Germany
9.2.4. Italy
9.2.5. Spain
9.2.6. Others
9.3. APAC
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. Australia
9.3.5. Others
9.4. ROW
9.4.1. South Africa
9.4.2. Russia
9.4.3. Saudi Arabia
9.4.4. Others
10. Cardiology Defibrillator Devices Market – Market Entropy
10.1. New Product Launches
10.2. M&As, Collaborations, JVs and Partnerships
11. Company Profiles
11.1. Bayer Animal Health (A Subsidiary of Bayer Ag)
11.2. Biomin Holding Gmbh
11.3. Bioniche Animal Health (A Division of Bioniche Life Sciences, Inc.)
11.4. Boehringer Ingelheim
11.5. Bupo Animal Health (PTY)
11.6. Cargill, Inc.
11.7. Elanco Animal Health (A Division of Eli Lilly and Company)
11.8. Merck Animal Health (A Subsidiary of Merck & Co., Inc.)
11.9. Royal Dsm N.V.
11.10. Zoetis, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
“”*Financials would be provided on a best efforts basis for private companies””
12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer”
“11.1. Bayer Animal Health (A Subsidiary of Bayer Ag)
11.2. Biomin Holding Gmbh
11.3. Bioniche Animal Health (A Division of Bioniche Life Sciences, Inc.)
11.4. Boehringer Ingelheim
11.5. Bupo Animal Health (PTY)
11.6. Cargill, Inc.
11.7. Elanco Animal Health (A Division of Eli Lilly and Company)
11.8. Merck Animal Health (A Subsidiary of Merck & Co., Inc.)
11.9. Royal Dsm N.V.
11.10. Zoetis, Inc.”
